IP Library Patent Application 17506849
Patent Application
App. No. 17/506,849

ADJUSTABLE ILLUMINATORS AND METHODS FOR PHOTODYNAMIC THERAPY AND DIAGNOSIS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/506,849
Abstract

An illuminator for photodynamically diagnosing or treating a surface includes a plurality of panels. The illuminator further includes a plurality of light sources, each mounted to one of the plurality of panels. The plurality of light sources are configured to irradiate the surface with substantially uniform intensity visible light. The illuminator also includes a heat source configured to emit heat to a patient. The heat increases the generation of a photoactivatable agent and thus shortens the time needed to complete photodynamic therapy

Claims (22)

1 . A method of photodynamically treating a patient for actinic keratosis, comprising:

applying a topical composition comprising 5-aminolevulinic acid (ALA) to an actinic keratosis lesion on the skin of a patient;

after applying the ALA, applying heat to the skin of the patient for a first time period; and

after the first time period, for a second time period simultaneously (1) applying heat to the skin of the patient and (2) illuminating the skin of the patient with light.

2 . The method as set forth in claim 1 , wherein the topical composition comprises a 5-aminolevulinic acid salt.

3 . The method as set forth in claim 1 , wherein the topical composition comprises about 20% 5-aminolevulinic acid salt.

4 . The method as set forth in claim 1 , wherein the topical composition comprises about 10% 5-aminolevulinic acid salt.

5 . The method as set forth in claim 1 , wherein the illuminating comprises illuminating with a dose of light of about 10 J/cm 2 .

6 . The method as set forth in claim 1 , wherein the illuminating comprises illuminating with a dose of light of about 20 J/cm 2 .

7 . The method as set forth in claim 1 , wherein the illuminating comprises illuminating with an irradiance density of 20 mW/cm 2 .

8 . The method as set forth in claim 1 , wherein the illuminating comprises illuminating with blue light.

9 . The method as set forth in claim 1 , wherein the illuminating comprises illuminating with red light.

10 . The method as set forth in claim 1 , wherein applying the topical composition comprises applying the ALA to actinic keratosis lesions on the face of the patient.

11 . The method as set forth in claim 1 , wherein heat and light illumination are simultaneously applied for about 20 minutes.

12 . The method as set forth in claim 1 , wherein heat and light illumination are simultaneously applied for about 10 minutes.

13 . The method as set forth in claim 1 , wherein heat is applied via at least one heating pad.

14 . The method as set forth in claim 1 , wherein heat is applied by directing warm air towards the patient.

15 . The method as set forth in claim 1 , wherein heat is applied using at least one infrared light source.

16 . The method as set forth in claim 1 , wherein heat is applied to reach a skin temperature of about 40° C.±2° C.

17 . The method as set forth in claim 1 , wherein the first time period is about 5 minutes and the second time period is about 10 minutes.

18 . The method as set forth in claim 1 , wherein the first time period is about 5 minutes.

19 . The method as set forth in claim 1 , wherein the second time period is about 10 minutes.

Assignments (2)
MERGER Recorded May 30, 2024
From: DUSA PHARMACEUTICALS, INC.
To: SUN PHARMACEUTICAL INDUSTRIES, INC.
Reel/Frame 067565/0986 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2024
From: BOYAJIAN, THOMAS; CAROTA, MARK; MAZEJKA, BRIAN; LECCESE, MICHAEL
To: DUSA PHARMACEUTICALS, INC.
Reel/Frame 067554/0402 →